Agree in that there will be further releases in the following months.
From January, although could be alittle later, we will all have clear and concise knowledge how ATH434 faired treating both 201 and 202 participants.
From here it will be upto the FDA to give the green light afew months after the final report submission.
If read outs continue to be impressive, which I strongly believe they will be, alot more companies will be knocking on the door with deals ready to be signed.
Just over 16wks (4months) until the trials are complete, this time will fly by.
Meetings this year, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
